Table of Contents
Insider Trades Summary: ASX 200 Directors (29 May – 5 June 2025)
Welcome to this week’s edition of the Insider Trades Series, where we provide insights into significant on-market transactions by directors of companies listed on the ASX 200, focusing on trades valued over $10,000. These transactions occurred between 29 May and 5 June 2025, with directors having a maximum of five business days to disclose their trades to the ASX.
Notable Insider Purchases
| Code | Company | Date | Director | Type | Price | Value |
|---|---|---|---|---|---|---|
| NEC | Nine Entertainment | 5/06/25 | Peter Tonagh | Buy | $1.62 | $199,935 |
| ELD | Elders | 29/05/25 | Damien Frawley | Buy | $6.25 | $125,000 |
| EBO | Ebos Group | 30/05/25 | Mark Bloom | Buy | $34.40 | $68,800 |
Insights:
-
Peter Tonagh, an experienced media figure and former CFO of Foxtel, has made a notable entry into Nine Entertainment, purchasing shares following a successful year, with the stock appreciating by approximately 30%. Factors contributing to this performance include positive advertising revenue trends, strategic acquisitions, and a robust third-quarter update that highlighted strong television ad revenues and enhanced profitability forecasts.
- Damien Frawley, who joined Elders’ board in 2024, acquired shares amidst a recent dip in stock value, down 13% year-to-date due to underwhelming financial results. Despite reporting a year-on-year revenue increase, the figures fell short of market expectations, influencing the stock price. Nevertheless, optimistic projections for the second half of the year are bolstered by robust livestock demand.
Noteworthy Insider Sales
| Code | Company | Date | Director | Type | Price | Value |
|---|---|---|---|---|---|---|
| SIG | Sigma Healthcare | 29/05/25 | Danielle Di Pilla | Sell | $3.18 | $23,312,794 |
| BVS | Bravura Solutions | 2/06/25 | Matthew Quinn | Sell | $2.50 | $1,249,500 |
| GNC | GrainCorp | 30/05/25 | Robert Spurway | Sell | $7.54 | $797,851 |
Insights:
-
Danielle Di Pilla, Executive Director at Sigma Healthcare, divested a substantial quantity of shares (approximately 29.8 million), retaining a significant stake of 75.6 million shares. Following a report indicating strong earnings growth, the company faced market apprehension over potential slowing growth in its Chemist Warehouse segment.
- Robert Spurway, CEO of GrainCorp, disposed of 105,872 shares, approximately 16% of his holdings, primarily to satisfy tax obligations related to performance rights. Despite this sale, the stock has shown resilience, rallying after the release of strong performance results that exceeded analyst expectations, along with an updated share buyback program and an increased dividend declaration.
Summary
This week’s insider trading highlights from directors within the ASX 200 reflect a mix of strategic buying and selling actions aligned with both personal financial obligations and broader company performance. The positive trends observed in some companies underscore confidence in future growth prospects, while others reveal caution amidst economic challenges. The interplay of personal investment decisions and corporate health will continue to shape the landscape in the coming months.
Stay tuned for further updates in the Insider Trades Series, as we track movements that reflect the sentiment and strategies of ASX 200 directors.
